Diabetic peripheral neuropathic pain
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
peripheral neuropathy complication of diabetes mellitus |
| gptkbp:affects |
peripheral nerves
|
| gptkbp:cause |
gptkb:depression
anxiety sleep disturbances reduced quality of life impaired mobility |
| gptkbp:complication |
gptkb:type_2_diabetes_mellitus
gptkb:type_1_diabetes_mellitus |
| gptkbp:diagnosedBy |
clinical examination
nerve conduction studies patient history |
| gptkbp:hasUMLSConceptID |
C0011880
|
| https://www.w3.org/2000/01/rdf-schema#label |
Diabetic peripheral neuropathic pain
|
| gptkbp:ICD-10_code |
G63.2
|
| gptkbp:MeSH_ID |
gptkb:D003928
|
| gptkbp:pathology |
inflammation
oxidative stress altered pain signaling microvascular injury nerve damage due to chronic hyperglycemia |
| gptkbp:prevalence |
common in long-standing diabetes
|
| gptkbp:prevention |
lifestyle modification
blood pressure control lipid management tight glycemic control |
| gptkbp:prognosis |
chronic condition
may worsen over time |
| gptkbp:riskFactor |
smoking
hypertension dyslipidemia poor glycemic control duration of diabetes |
| gptkbp:symptom |
numbness
tingling burning pain allodynia hyperalgesia |
| gptkbp:synonym |
diabetic nerve pain
diabetic neuropathic pain painful diabetic neuropathy |
| gptkbp:treatment |
gptkb:tricyclic_antidepressants
gptkb:gabapentin gptkb:pregabalin gptkb:duloxetine opioids topical capsaicin |
| gptkbp:bfsParent |
gptkb:DB01452
|
| gptkbp:bfsLayer |
7
|